# Effect of Testosterone Treatment on Embryo Quality

> **NCT01662466** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Center for Human Reproduction** · enrollment: 180 (estimated)

## Conditions studied

- Primary Ovarian Insufficiency
- Female Infertility Due to Diminished Ovarian Reserve

## Interventions

- **DRUG:** Testosterone cream (0.5mg per gram)
- **DIETARY_SUPPLEMENT:** DHEA
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01662466
- **Lead sponsor:** Center for Human Reproduction
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-07-01
- **Primary completion:** 2022-06-01
- **Final completion:** 2022-12-31
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2020-11-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01662466

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01662466, "Effect of Testosterone Treatment on Embryo Quality". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01662466. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*